Therapeutics announced that the U.S. FDA has granted Fast Track designation for rezpegaldesleukin for the treatment of adult and ...
Silverberg, J.I., Rosmarin, D., Chovatiya, R. et al. The regulatory T cell-selective interleukin-2 receptoragonist rezpegaldesleukin in the treatment of inflammatory ...
To present the pioneering concept, Peer and his team encoded the anti-inflammatory protein interleukin-10 into mRNA and ...
Left to right - Dr. Riccardo Rampado & Prof. Dan Peer. Researchers at Tel Aviv University have achieved a breakthrough in ...
Researchers at the University of Liège (Belgium) have uncovered a previously unknown mechanism that regulates the immune ...
More than 90% of Omvoh-treated patients who were in clinical remission at one year sustained it with two years of continuous treatment Omvoh works to reduce inflammation within the gastrointestinal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results